BTO Sema4 Holdings L.P.

BTO Sema4 Holdings L.P. appears in our data through filings on GeneDx Holdings Corp. shares, published by SEC (Form 4). We count 3 filings, every one of them for a trade on 29 April 2022.

Every open-market trade on record is a purchase: 3 purchases worth €9.5M, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The median purchase comes to €192k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Ninety days after publication, 3 purchases show a median change of -26.6%, with the price up in 0% of them. This is a record of the past, not a forecast.

On 3 May 2022 came the latest disclosure, an open-market purchase for €192k in GeneDx Holdings Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.